(4-tert-butylpiperazin-2-yl)(piperazin-1-y l)methanone-N-carboxamide derivatives

Details for Australian Patent Application No. 2009327575 (hide)

Owner AstraZeneca AB

Inventors Cumming, John; Faull, Alan Wellington; Waterson, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009327575

PCT Pub. Number WO2010/071567

Priority 61/122,445 15.12.08 US

Filing date 14 December 2009

Wipo publication date 24 June 2010

International Classifications

C07D 295/185 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/071567 Priority application(s): WO2010/071567

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009327592-Superabsorbent polymer composite comprising a superabsorbent polymer and cellulosic nanofibrils

2009327574-Gyratory crusher with arrangement for restricting rotation